At the end of the 19th century William Osler noted key differences in the presentation of pneumonia in the elderly. His observational perspicuity has withstood the passage of time. The following article pays deference to this Canadian physician, summarizing not only differences in clinical presentation but also including an update on epidemiology, aetiology and management.
Introduction
It is a mistake to consider pneumonia in the elderly patients simply in terms of the clinical manifestation of adult pneumonia in an older person. Pneumonia in old age should be considered as a distinct entity with recognition of age-associated differences in epidemiology, aetiology, clinical presentation and management.
Definitions
Pneumonia can be defined as symptoms and signs consistent with an acute lower respiratory tract infection associated with new radiographic shadowing for which there is no other explanation. In the community, where access to imaging is limited, pneumonia can be presumed if indicated by 'a complex of symptoms and signs both from the respiratory tract and regarding the general health of the patient.' In particular, this could include features such as a temperature >38 C, dyspnoea, tachypnoea and new localizing chest signs. 1 Old age is harder to define with no agreed cut-off. Studies have opted for a wide variety of different ages ranging from as low as 60 to over 79 years of age.
Epidemiology and aetiology
The incidence of pneumonia by age shows an almost bell-shaped curve indicating the significant increase in frequency at the extremes of life (see Figure 1 ). 2 Similarly, age predicts mortality as exemplified by the CURB65 severity index, with age >65 representing 1 of 5 independent predictors of 30-day mortality. 3 In addition to an increase in incidence and mortality, the microbiology also differs. There is a significant increase in the incidence of Streptococcus pneumoniae and a concomitant lower incidence of Legionella and Mycoplasma. 4, 5 Haemophilus influenzae is probably more common in the elderly patient although the evidence is less clear. Given the reduction in the incidence of Legionella and atypical pathogens, this favours antibiotic regimens using beta-lactam antibiotic monotherapy, such as amoxicillin, in those with mild-to-moderate infection.
William Osler and the presentation of old age pneumonia
In 1892, William Osler summarized the key differences in the presentation of pneumonia, 'In old age pneumonia may be latent, . . . coming on without a chill, the cough and expectoration are slight, . . . the physical findings ill-defined and changeable . . . and the constitutional symptoms out of proportion to the extent of the local lesion. 6 His perspicuity remains as pertinent today as it was in the 19th century. The classic symptoms of fever, cough, sputum production, dyspnoea and pleuritic chest pain may be absent or diminished. Chest signs may not feature. Instead, the elderly patient may present with more slowly progressive, nonspecific features of ill health. Key clinical features might include unexplained confusion, falls, decreased appetite or headache. Clinical features may be as general as widespread general aches or fatigue.
Imaging
By definition, the diagnosis of community-acquired pneumonia requires chest X-ray confirmation. However, given logistic and cost implications, it is possible to diagnose community-acquired pneumonia without chest X-ray. This presumptive diagnosis can be formulated as a complex of symptoms and signs consistent with community-acquired pneumonia, particularly if the patient is febrile in association with new focal crackles. However, caution is warranted. Pneumonia is not synonymous with 'Chest infection,' 'Acute Bronchitis' or 'Infective exacerbation of chronic obstructive pulmonary disease (COPD)'. The term, chest infection is more generic, encompassing both pneumonia and non-pneumonic chest sepses. Acute bronchitis and infective exacerbation of COPD indicate infection restricted to the bronchial tree and not the lung parenchyma. The course of the infection and clinical management are distinct and the terms should not be used interchangeably. Therefore, when in doubt, a chest X-ray is invaluable. Not only can this distinguish those with consolidation who may benefit from more intensive antibiotic treatment but also can help rule out other pathology such as malignancy and pleural disease.
The timing of the repeat film should be extended in the elderly patient. In one study, 73% of younger patients had a normal chest X-ray by 6 weeks, in contrast to older patients where only 60% were normal at the same time interval. However, by 12 weeks, the 60% had increased to 84%. 7 This author suggests an 8-week chest X-ray follow-up in the elderly patient. This time interval represents a compromise between an allowance for the longer lag time for radiographic clearing, but not so long as to delay identifying those with occult malignancy.
Microbial culture
The value of sputum culture is limited due to the inability of a patient to produce a good specimen, poor yield as a consequence of prior antibiotics or a delay in processing and difficulty in distinguishing organisms from the upper airway. However, the elderly patients are more prone to Staphylococcus aureus pneumonia following influenza infection, 8 thus indicating the need for a broad-spectrum antimicrobial. However, wherever applicable, a narrow spectrum penicillin will reduce adverse effects such as antibiotic-related diarrhoea or liver toxicity. In addition, narrow spectrum antibiotics are preferable from a public health perspective, with a reduction in selective pressure driving antibiotic resistance. 9 Therefore, sputum culture should be requested for moderate or severe pneumonia in antibiotic-naive patients with purulent sputum. In addition, it is important to recognize the importance of rapid transport to the laboratory. 1, 10 Similarly, blood cultures should be requested for moderate-to-severe pneumonia before antibiotic treatment has been started. This test has low sensitivity but high specificity.
Prognostic features
CURB65 and its primary care counterpart, CRB65, are easy-to-use tools allowing severity scores for non-severe, moderate and severe pneumonia. 11 Table  1 lists the 6 point severity scoring system predictive of 30 day mortality. As well as being 65 or older, increased age is also likely to result in a higher score due to common age-associated co-morbidities. It should be added this severity score is only one component of severity assessment and should be used in conjunction with clinical judgement, assessment of co-morbidities and social circumstances. Other poor prognostic markers include: lack of pyrexia, being bed-ridden and admission from a nursing home. 1, 12 Frequency, severity and mortality are high -why?
Pneumonia in old age is more frequent, severe and associated with a high mortality. This is due to multiple factors. Aging leads to organ system dysfunction, particularly respiratory, gastrointestinal and immunological senescence. Sputum clearance is less effective, risk of aspiration increased and there is an overall decline in lymphocyte, neutrophil, NK cell and antigen presenting cell function. In addition, aging is associated with a stepwise increase in co-morbidities such as diabetes, malignancy, COPD and organ failures. Many elderly patients who develop pneumonia are established on multiple medications. Polypharmacy may lead to poor antibiotic adherence due to the problem of pill burden. Opiates may suppress the cough reflex and steroids result in increased risk of infection. For example, the TORCH trial examined the impact of inhaled fluticasone with or without salmeterol in COPD. There was an increased risk of pneumonia in the limbs given inhaled corticosteroids compared with placebo -about 19% versus 12% (p<0.001). 13 
Influenza vaccination
Vaccination has been used to reduce the impact of influenza in the elderly for over 40 years. Most authorities recommend seasonal vaccination for 65 years or older. However, whilst there is clear meta-analysis evidence for benefit of influenza vaccination for nursing home residents, the evidence for those in the community is limited. 14 
In a subsequent
Cochrane review, the authors identified only one randomised control trial (RCT) and this showed some symptom benefit, but numbers were underpowered to detect an effect on complications. The uncertainty over efficacy will remain until there is a larger RCT requiring more than a single season of assessment. 15 Nursing home-acquired pneumonia
Nursing-home acquired pneumonia (NHAP) should be distinguished from CAP. However, differences vary by country. In the US, there is a different pattern of organisms in NHAP including Gram-negative aerobes and anaerobes. 16 This may reflect the different and more intensive level of healthcare provision in these institutions. In contrast, there was no clear difference in microbiological diversity between CAP and NHAP in the UK. 17 However, overall NHAP has been associated with a higher incidence in of aspiration pneumonia, increased comorbid illness, worse severity and increased mortality. 18 
Aspiration pneumonia
Aspiration pneumonia is said to occur when a pneumonic process is associated with aspiration of colonised nasopharyngeal or gastric contents. In reality, this diagnostic label is used for pneumonia in those at high risk of aspiration. There is a higher incidence of aspiration in the elderly. Moreover, when elderly patients with CAP are compared with matched controls, silent aspiration was significantly more common (71% versus 10%). 19 This association doesn't indicate causation, but it is more than likely that aspiration pneumonia is more frequent in the elderly.
End-of-life pneumonia (EOLP)
It's important to distinguish a sub-group of pneumonia cases associated with terminal illness. Usually, attributable mortality from pneumonia is low with death resulting from other cancer related causes. The decision to use antibiotics is complex and requires careful judgement with a consideration of patient wishes in the context of palliative goals. It many situations, it is reasonable to consider antibiotic use only if this results in alleviation of suffering.
Conclusion
William Osler rightly identified pneumonia in old age as a distinct clinical entity. Non-specific systemic symptoms may overshadow characteristic symptoms of cough, purulent sputum and breathlessness and be replaced with 'falls' or 'confusion'. Having identified CAP in the elderly, severity scoring using CRB65 or CURB65 will assist risk stratification and decisions concerning placement and treatment. In addition, it is important to decrease risk of development of CAP utilising immunization, nutrition, reducing the risk of aspiration, offering smoking cessation support, optimising management of comorbidity and maintaining functional status wherever possible.
